Baseline clinical characteristics of the study population dependent on the results of genetic testing
Demographics | |||
Positive Genetic Test (n=40) | Negative Genetic Test (n=103) | p value | |
Atrial fibrillation (n) | 3 | 20 | 0.08 |
No Atrial fibrillation (n) | 37 | 83 | |
Demographics | |||
Age (years) | 60 ± 13 | 63 ± 11 | 0.22 |
Females (n) | 12 | 40 | 0.3 |
Medical History | |||
Prior Myocardial Infarction (n) | 16 | 34 | 0.43 |
LV ejection fraction < 40% (n) | 8 | 17 | 0.62 |
Hypertension (n) | 23 | 81 | 0.01 |
Diabetes (n) | 16 | 33 | 0.37 |
Asthma/COPD (n) | 3 | 19 | 0.10 |
Stroke/TIA (n) | 5 | 9 | 0.34 |
Preoperative Therapies | |||
Statin (n) | 29 | 65 | 0.28 |
β blocker (n) | 26 | 66 | 0.75 |
ACE inhibitor (n) | 17 | 49 | 0.58 |
Digoxin (n) | 0 | 1 | 0.72 |
Metoprolol (n) | 12 | 27 | 0.65 |
Amiodarone (n) | 7 | 26 | 0.32 |
Atrial Pacing (n) | 8 | 26 | 0.51 |
Combination (n) | 13 | 24 | 0.26 |
Form of Surgery | |||
Coronary Bypass (n) | 32 | 82 | 0.58 |
Valve Surgery (n) | 7 | 15 | 0.66 |
Both (n) | 1 | 6 | 0.37 |
Off Pump (n) | 27 | 66 | 0.70 |